Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Parsons Corporation (PSN)

Parsons Corporation missed Q2 CY2026 consensus revenue estimates, posted a net loss, and reported adjusted EBITDA down roughly 72% year over year — and the stock dropped 35%

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) reported second quarter CY2026 revenue of approximately $1.58 billion to $1.60 billion against consensus of $1.61 billion, along with a net loss of roughly $15 million and adjusted EBITDA of about $42 million — down approximately 72% from the prior-year period. Shares sold off 35% following the report. If you lost money on PSN, you are encouraged to submit your losses for review now. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

Revenue came in about 1% below the prior-year quarter. Management attributed the shortfall to “planned divestitures,” “lower pass-through costs,” and “federal contract timing,” as well as a confidential fixed-price contract that was ”canceled by the administration.”

Alongside the miss, Parsons cut full-year 2026 revenue guidance to $6.2 billion to $6.5 billion, from $6.5 billion to $6.8 billion, and reduced full-year adjusted EBITDA guidance to $500 million to $560 million, from $615 million to $675 million — a reduction of as much as $115 million at the top end. The reductions were disclosed via Form 8-K on July 29, 2026. Levi & Korsinsky is investigating potential securities law violations on behalf of PSN investors.

Shareholders who purchased Parsons stock and suffered a loss may request a free case evaluation here, or call (212) 363-7500.

ABOUT THE FIRM — For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years.

Frequently Asked Questions About the PSN Investigation

Q: How much did PSN stock drop? A: Shares declined 35% following the July 29, 2026 disclosure of a surprise quarterly net loss and a steep drop in adjusted EBITDA. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek recovery.

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Parsons Corporation made materially false or misleading statements regarding its full-year 2026 revenue and adjusted EBITDA outlook. When the Company cut guidance on July 29, 2026, the stock price declined 35%.

Q: Who is eligible to participate in the PSN investigation? A: Investors who purchased PSN stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: What do PSN investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my PSN shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought PSN and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis — no retainer and no out-of-pocket costs.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212) 363-7500

Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.